Menu
Back to Journals » OncoTargets and Therapy » Volume 12
PLK1 as a potential prognostic marker of gastric cancer through MEK-ER K pathway on PDTX models [Corrigendum]
Dang SC, Fan YY, Cui L, Chen JX, Qu JG, Gu M. Onco Targets Ther. 2018;11:6239–6247.
On page 6239, 2nd affiliation was listed as “Zhenjiang Integrative Medicine Hospital, Zhenjiang, Jiangsu Province, People’s Republic of China” however it should have been “Zhenjiang Hospital of Traditional Chinese and Western Medicine, Zhenjiang, Jiangsu, People’s Republic of China” On page 6239, Correspondence address was listed as “Zhenjiang Integrative Medicine Hospital, Zhenjiang, Jiangsu Province, People’s Republic of China” however it should have been “Zhenjiang Hospital of Traditional Chinese and Western Medicine, Zhenjiang, Jiangsu 212001, People’s Republic of China”.
© 2019 The Author(s). This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License.
By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.